BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang FH, Shen L, Li J, Zhou ZW, Liang H, Zhang XT, Tang L, Xin Y, Jin J, Zhang YJ, Yuan XL, Liu TS, Li GX, Wu Q, Xu HM, Ji JF, Li YF, Wang X, Yu S, Liu H, Guan WL, Xu RH. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond). 2019;39:10. [PMID: 30885279 DOI: 10.1186/s40880-019-0349-9] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 41.0] [Reference Citation Analysis]
Number Citing Articles
1 Ossola P, Mascioli F, Coletta D, Bononi M. Laparoscopic Mesogastrium Excision for Gastric Cancer: Only the Beginning. J Laparoendosc Adv Surg Tech A 2021;31:371-4. [PMID: 33052765 DOI: 10.1089/lap.2020.0743] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Sun KK, Wang QH, Wu YY. Challenges surrounding postoperative adjuvant chemotherapy for T2N0 gastric cancer. Oncol Lett 2020;20:126. [PMID: 32934695 DOI: 10.3892/ol.2020.11985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Lv D, Xing C, Cao L, Zhuo Y, Wu T, Gao N. PD-L1 gene promoter methylation represents a potential diagnostic marker in advanced gastric cancer. Oncol Lett 2020;19:1223-34. [PMID: 31966052 DOI: 10.3892/ol.2019.11221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Guo X, Zhao F, Ma X, Shen G, Ren D, Zheng F, Du F, Wang Z, Ahmad R, Yuan X, Zhao J, Zhao J. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2019;19:1125. [PMID: 31747911 DOI: 10.1186/s12885-019-6294-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li LB, Fang TY, Xu WJ. Oral glutamine inhibits tumor growth of gastric cancer bearing mice by improving immune function and activating apoptosis pathway. Tissue Cell 2021;71:101508. [PMID: 33609891 DOI: 10.1016/j.tice.2021.101508] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Barchi LC, Ramos MFKP, Dias AR, Andreollo NA, Weston AC, LourenÇo LG, Malheiros CA, Kassab P, Zilberstein B, Ferraz ÁAB, Charruf AZ, Brandalise A, Silva AMD, Alves B, Marins CAM, Leite CV, Bresciani CJC, Szor D, Mucerino DR; Consensus. II BRAZILIAN CONSENSUS ON GASTRIC CANCER BY THE BRAZILIAN GASTRIC CANCER ASSOCIATION. Arq Bras Cir Dig 2020;33:e1514. [PMID: 32844884 DOI: 10.1590/0102-672020190001e1514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
7 Li X, Chu Y, Song Q, Hu Q, Xu Y. The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/3308801] [Reference Citation Analysis]
8 Zhu Z, Gong YB, Xu HM. Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges. Chronic Dis Transl Med 2020;6:147-57. [PMID: 32908968 DOI: 10.1016/j.cdtm.2020.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Chen L, Zhang C, Yao Z, Cui M, Xing J, Yang H, Zhang N, Liu M, Xu K, Tan F, Li Y, Jiang B, Su X. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study. BMC Cancer 2021;21:974. [PMID: 34461860 DOI: 10.1186/s12885-021-08717-4] [Reference Citation Analysis]
10 Wang N, Xi W, Lu S, Jiang J, Wang C, Zhu Z, Yan C, Liu J, Zhang J. A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy. Front Oncol 2021;11:650562. [PMID: 34195071 DOI: 10.3389/fonc.2021.650562] [Reference Citation Analysis]
11 Sui A, Hu Z, Xie X, Deng Y, Wang Y, Yu J, Shen L. Automatic Detection of Gastric Wall Structure Based on Oral Contrast-Enhanced Ultrasound and Its Application on Tumor Screening. Front Oncol 2021;11:627556. [PMID: 33854966 DOI: 10.3389/fonc.2021.627556] [Reference Citation Analysis]
12 Wang Y, Zou J, Hu L, Liu Q, Huang R, Tang T, Yue Q, Sun Y, Xiao Q, Zeng X, Zeng Y. What is the general Chinese public’s awareness of and attitudes towards Helicobacter pylori screening and associated health behaviours? A cross-sectional study. BMJ Open 2022;12:e057929. [DOI: 10.1136/bmjopen-2021-057929] [Reference Citation Analysis]
13 Gao Q, Wu Y, Lu C, Kai W, Xie W, Wang Q, Wang L, Liu S, Pan Y. Knockdown of RREB1 inhibits cell proliferation via enhanced p16 expression in gastric cancer. Cell Cycle 2021;20:2465-75. [PMID: 34666611 DOI: 10.1080/15384101.2021.1987676] [Reference Citation Analysis]
14 Wei J, Xu H, Wei W, Wang Z, Zhang Q, De W, Shu Y. circHIPK3 Promotes Cell Proliferation and Migration of Gastric Cancer by Sponging miR-107 and Regulating BDNF Expression. Onco Targets Ther 2020;13:1613-24. [PMID: 32110057 DOI: 10.2147/OTT.S226300] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
15 Mirniaharikandehei S, Heidari M, Danala G, Lakshmivarahan S, Zheng B. Applying a random projection algorithm to optimize machine learning model for predicting peritoneal metastasis in gastric cancer patients using CT images. Comput Methods Programs Biomed 2021;200:105937. [PMID: 33486339 DOI: 10.1016/j.cmpb.2021.105937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wu X, Li D, Chen H, Han J, Zhou H, He Z, Ma Y, Dong B, Wu Y, Matkowskyj KA, Ejaz A, Almhanna K, Wang Q. Evaluation of the reporting quality of guidelines for gastric cancer using the RIGHT checklist. Ann Transl Med 2021;9:1003. [PMID: 34277803 DOI: 10.21037/atm-21-2491] [Reference Citation Analysis]
17 Bi Y, Zhang J, Zeng D, Chen L, Ye W, Yang Q, Ling Y. Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer. Pathol Oncol Res 2021;27:580800. [PMID: 34257526 DOI: 10.3389/pore.2021.580800] [Reference Citation Analysis]
18 Gao S, Li N, Wang S, Zhang F, Wei W, Li N, Bi N, Wang Z, He J. Lung Cancer in People’s Republic of China. Journal of Thoracic Oncology 2020;15:1567-76. [DOI: 10.1016/j.jtho.2020.04.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
19 Wang Y, Zhang J, Guo S, Meng XY, Zheng ZC, Zhao Y. Indications of neoadjuvant chemotherapy for locally advanced Gastric Cancer patients based on pre-treatment clinicalpathological and laboratory parameters. J Cancer 2020;11:6000-8. [PMID: 32922540 DOI: 10.7150/jca.46430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wang F, Xue Q, Xu D, Jiang Y, Tang C, Liu X. Identifying the hub gene in gastric cancer by bioinformatics analysis and in vitro experiments. Cell Cycle 2020;19:1326-37. [PMID: 32293980 DOI: 10.1080/15384101.2020.1749789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Chen Y, Xu W, Li YL, Liu W, Sah BK, Wang L, Xu Z, Wels M, Zheng Y, Yan M, Zhang H, Ma Q, Zhu Z, Li C. CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy. Front Oncol 2022;12:758863. [PMID: 35280802 DOI: 10.3389/fonc.2022.758863] [Reference Citation Analysis]
22 Liu W, Li Y, Zhang Y, Shen X, Su Z, Chen L, Cai W, Wang F, Ju S. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer. Pathology - Research and Practice 2020;216:152757. [DOI: 10.1016/j.prp.2019.152757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Shao Q, Wang F, Xu Y, Zhang X, Tang W, Feng Y, Li Y. CDKL2 Is Associated with HER2 Status and Overall Survival in Gastric Cancer: Comparative Analysis of CDKL2 Protein Expression and Gene Copy Number. Biomed Res Int 2020;2020:1712723. [PMID: 33178818 DOI: 10.1155/2020/1712723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Li B, Yu-Hong Wong I, Siu-Yin Chan F, Chan KK, Lai-Yin Wong C, Law TT, Yat-Yin Kwok J, Law S. Comparison of laparoscopic versus open gastrectomy for gastric cancer. Surg Oncol 2020;35:14-21. [PMID: 32781394 DOI: 10.1016/j.suronc.2020.06.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Cai Z, Rui W, Li S, Fingerhut A, Sun J, Ma J, Zang L, Zhu Z, Zheng M. Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer. Front Oncol 2020;10:614785. [PMID: 33384963 DOI: 10.3389/fonc.2020.614785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Pan S, Wang P, Xing Y, Li K, Wang Z, Xu H, Zhu Z. Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis. Cancer Commun (Lond) 2019;39:49. [PMID: 31519217 DOI: 10.1186/s40880-019-0394-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
27 Liu Q. Laparoscopy-assisted Distal Gastrectomy should become a Standard Surgical Treatment Option for Stage IA/IB Gastric Cancer. Glob Med Genet 2021;8:39-40. [PMID: 33987621 DOI: 10.1055/s-0041-1725071] [Reference Citation Analysis]
28 Liu M, Xu W, Su M, Fan P. REC8 suppresses tumor angiogenesis by inhibition of NF-κB-mediated vascular endothelial growth factor expression in gastric cancer cells. Biol Res 2020;53:41. [PMID: 32958054 DOI: 10.1186/s40659-020-00307-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
29 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Fan Z, Pan J, Wang H, Zhang Y. NOD-like receptor X1, tumor necrosis factor receptor-associated factor 6 and NF-κB are associated with clinicopathological characteristics in gastric cancer. Exp Ther Med 2021;21:208. [PMID: 33574909 DOI: 10.3892/etm.2021.9640] [Reference Citation Analysis]
31 You Q, Fang T, Yin X, Wang Y, Yang Y, Zhang L, Xue Y. Serum CD4 Is Associated with the Infiltration of CD4+T Cells in the Tumor Microenvironment of Gastric Cancer. J Immunol Res 2021;2021:6539702. [PMID: 34258299 DOI: 10.1155/2021/6539702] [Reference Citation Analysis]
32 Bei Y, Chen X, Xu Q, Lv J, Hu J, Yang S. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway. Drug Dev Res 2021. [PMID: 34405891 DOI: 10.1002/ddr.21867] [Reference Citation Analysis]
33 Zhang C, Li D, Yu R, Li C, Song Y, Chen X, Fan Y, Liu Y, Qu X. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Front Immunol 2021;12:651033. [PMID: 34054812 DOI: 10.3389/fimmu.2021.651033] [Reference Citation Analysis]
34 Liu J, Zhou L, Lin S, Yao B. Role of serum matrix metalloproteinase in the diagnosis of gastric cancer. Pak J Med Sci 2020;36:1025-31. [PMID: 32704283 DOI: 10.12669/pjms.36.5.2059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Jin P, Liu H, Ma FH, Ma S, Li Y, Xiong JP, Kang WZ, Hu HT, Tian YT. Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion . World J Clin Cases 2021; 9(29): 8718-8728 [PMID: 34734050 DOI: 10.12998/wjcc.v9.i29.8718] [Reference Citation Analysis]
36 Qiao X, Li Z, Li L, Ji C, Li H, Shi T, Gu Q, Liu S, Zhou Z, Zhou K. Preoperative T2-weighted MR imaging texture analysis of gastric cancer: prediction of TNM stages. Abdom Radiol (NY) 2021;46:1487-97. [PMID: 33047226 DOI: 10.1007/s00261-020-02802-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Zhang F, Li X, Chen H, Guo J, Xiong Z, Yin S, Jin L, Chen X, Luo D, Tang H, Mao C, Lian L. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer. Front Med (Lausanne) 2022;9:836892. [PMID: 35211490 DOI: 10.3389/fmed.2022.836892] [Reference Citation Analysis]
38 Hu W. Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy. Thorac Cancer 2020;11:3-5. [PMID: 31722117 DOI: 10.1111/1759-7714.13233] [Reference Citation Analysis]
39 Huang JB, Lu J, Wu D, Xu BB, Xue Z, Lin GS, Zheng HL, Shen LL, Lin J, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Zheng CH, Huang CM, Li P. Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer? Front Oncol 2021;11:712432. [PMID: 34513692 DOI: 10.3389/fonc.2021.712432] [Reference Citation Analysis]
40 Liu D, Zhang W, Hu F, Yu P, Zhang X, Yin H, Yang L, Fang X, Song B, Wu B, Hu J, Huang Z. A Bounding Box-Based Radiomics Model for Detecting Occult Peritoneal Metastasis in Advanced Gastric Cancer: A Multicenter Study. Front Oncol 2021;11:777760. [PMID: 34926287 DOI: 10.3389/fonc.2021.777760] [Reference Citation Analysis]
41 Cheng L, Chen S, Wu W, Kuo ZC, Wei Z, Meng S, Chen C, Zhang C, He Y. Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis. J Cancer Res Clin Oncol 2020;146:2937-47. [PMID: 32451690 DOI: 10.1007/s00432-020-03268-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Chen Y, Xiang J, Liu D, Xiao J, Xiong F, Wei K, Liu A, Chen S, Zhu Y, Meng X, Peng J. Multidisciplinary team consultation for resectable Gastric Cancer: A propensity score matching analysis. J Cancer 2021;12:1907-14. [PMID: 33753988 DOI: 10.7150/jca.53365] [Reference Citation Analysis]
43 Lei L, Li N, Yuan P, Liu D. A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer. BMC Cancer 2022;22:365. [PMID: 35382776 DOI: 10.1186/s12885-021-09062-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kang SH, Kim HH. Laparoscopic surgery for gastric cancer: Current status and future direction. Chin J Cancer Res 2021;33:133-41. [PMID: 34158733 DOI: 10.21147/j.issn.1000-9604.2021.02.01] [Reference Citation Analysis]
45 Sheng Q, Zhang GD, Wen MY. Value of serum G-17, PGⅠ, PGⅡ, Hp-IgG in the screening of gastric cancer and precancerous lesions and its relationship with the depth of tumor invasion. Shijie Huaren Xiaohua Zazhi 2022; 30(5): 235-241 [DOI: 10.11569/wcjd.v30.i5.235] [Reference Citation Analysis]
46 Yang K, Lu L, Liu H, Wang X, Gao Y, Yang L, Li Y, Su M, Jin M, Khan S. A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors. Expert Rev Gastroenterol Hepatol 2021;15:255-73. [PMID: 33121300 DOI: 10.1080/17474124.2021.1845140] [Reference Citation Analysis]
47 Huang Z, Liu D, Chen X, Yu P, Wu J, Song B, Hu J, Wu B. Retrospective imaging studies of gastric cancer: Study protocol clinical trial (SPIRIT Compliant). Medicine (Baltimore). 2020;99:e19157. [PMID: 32080093 DOI: 10.1097/md.0000000000019157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
48 Liu Y, Zhai E, Chen J, Qian Y, Zhao R, Ma Y, Liu J, Huang Z, Cai S, Chen J. m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels. Cancer Commun (Lond) 2022. [PMID: 35261206 DOI: 10.1002/cac2.12281] [Reference Citation Analysis]
49 Wang XZ, Zeng ZY, Ye X, Sun J, Zhang ZM, Kang WM. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines. World J Gastrointest Oncol 2020; 12(1): 37-53 [PMID: 31966912 DOI: 10.4251/wjgo.v12.i1.37] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
50 Liu Z, Wang Y, Shan F, Ying X, Zhang Y, Li S, Jia Y, Li Z, Ji J. 5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last? Cancer Manag Res 2021;13:147-61. [PMID: 33469359 DOI: 10.2147/CMAR.S285361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Wu W, Zhang F, Zhao J, He P, Li Y. The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer. Exp Cell Res 2022;:113115. [PMID: 35341774 DOI: 10.1016/j.yexcr.2022.113115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kassar S, Samaha R, Aoun R, Khoury M, Kattan J. The concept of oligometastatic disease in gastric cancer: reality or fiction? Future Oncol 2022;18:135-8. [PMID: 34889659 DOI: 10.2217/fon-2021-1315] [Reference Citation Analysis]
53 Wu T, Wang CH, Wang W, Liu LL, Yun JP, Zhou ZW. Association of preoperative and postoperative CA72-4 with gastric cancer outcome. J Surg Oncol 2021;123:1699-707. [PMID: 33684249 DOI: 10.1002/jso.26446] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Zhang YJ, Xiang RC, Li J, Liu Y, Xie SM, An L, Li HL, Mai G. Superior pancreatic lymphadenectomy with portal vein priority via posterior common hepatic artery approach in laparoscopic radical gastrectomy. World J Clin Cases 2022; 10(6): 1834-1842 [DOI: 10.12998/wjcc.v10.i6.1834] [Reference Citation Analysis]
55 Lin C, Fan H, Chen W, Cui L. Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Front Surg 2021;8:723065. [PMID: 34901136 DOI: 10.3389/fsurg.2021.723065] [Reference Citation Analysis]
56 Yan XL, Luo QY, Zhou SN, Pan WT, Zhang L, Yang DJ, Qiu MZ. MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer. Clin Res Hepatol Gastroenterol 2020;:101574. [PMID: 33272890 DOI: 10.1016/j.clinre.2020.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wu D, Wei C, Li Y, Yang X, Zhou S. Pyroptosis, a New Breakthrough in Cancer Treatment. Front Oncol 2021;11:698811. [PMID: 34381721 DOI: 10.3389/fonc.2021.698811] [Reference Citation Analysis]
58 Zhuo YJ, Shi Y, Wu T. NRP-1 and KDR polymorphisms are associated with survival time in patients with advanced gastric cancer. Oncol Lett 2019;18:4629-38. [PMID: 31611971 DOI: 10.3892/ol.2019.10842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
59 Sun Z, Jiang Y, Chen C, Zheng H, Huang W, Xu B, Tang W, Yuan Q, Zhou K, Liang X, Chen H, Han Z, Feng H, Yu S, Hu Y, Yu J, Zhou Z, Wang W, Xu Y, Li G. Radiomics signature based on computed tomography images for the preoperative prediction of lymph node metastasis at individual stations in gastric cancer: A multicenter study. Radiother Oncol 2021;165:179-90. [PMID: 34774652 DOI: 10.1016/j.radonc.2021.11.003] [Reference Citation Analysis]
60 Liao J, Qin H, Huang Z, Cai J, Mo X. Effect of Esophagus-Remnant Stomach Anterior Wall Anastomosis on Postoperative Reflux and Nutritional Status in Patients with Early- and Intermediate-Stage Proximal Gastric Cancer. J Laparoendosc Adv Surg Tech A 2021. [PMID: 33666512 DOI: 10.1089/lap.2021.0016] [Reference Citation Analysis]
61 Caruso S, Scatizzi M. Laparoscopic gastrectomy for gastric cancer: has the time come for considered it a standard procedure? Surg Oncol 2022;40:101699. [PMID: 34995972 DOI: 10.1016/j.suronc.2021.101699] [Reference Citation Analysis]
62 Qi Y, Qi W, Liu S, Sun L, Ding A, Yu G, Li H, Wang Y, Qiu W, Lv J. TSPAN9 suppresses the chemosensitivity of gastric cancer to 5-fluorouracil by promoting autophagy. Cancer Cell Int 2020;20:4. [PMID: 31911756 DOI: 10.1186/s12935-019-1089-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
63 Huang Z, Liu D, Chen X, He D, Yu P, Liu B, Wu B, Hu J, Song B. Deep Convolutional Neural Network Based on Computed Tomography Images for the Preoperative Diagnosis of Occult Peritoneal Metastasis in Advanced Gastric Cancer. Front Oncol 2020;10:601869. [PMID: 33224893 DOI: 10.3389/fonc.2020.601869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Zhang W, Zheng M, Kong S, Li X, Meng S, Wang X, Wang F, Tang C, Ju S. Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer. Front Oncol 2021;11:699625. [PMID: 34595108 DOI: 10.3389/fonc.2021.699625] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Wang W, Peng Y, Feng X, Zhao Y, Seeruttun SR, Zhang J, Cheng Z, Li Y, Liu Z, Zhou Z. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. JAMA Netw Open 2021;4:e2121143. [PMID: 34410397 DOI: 10.1001/jamanetworkopen.2021.21143] [Reference Citation Analysis]
66 Chung HC, Kang YK, Chen Z, Bai Y, Wan Ishak WZ, Shim BY, Park YL, Koo DH, Lu J, Xu J, Chon HJ, Bai LY, Zeng S, Yuan Y, Chen YY, Gu K, Zhong WY, Kuang S, Shih CS, Qin SK. Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients. Cancer 2021. [PMID: 34878659 DOI: 10.1002/cncr.34019] [Reference Citation Analysis]
67 He CY, Qiu MZ, Yang XH, Zhou DL, Ma JJ, Long YK, Ye ZL, Xu BH, Zhao Q, Jin Y, Lu SX, Wang ZQ, Guan WL, Zhao BW, Zhou ZW, Shao JY, Xu RH. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis. Clin Transl Med 2020;10:353-62. [PMID: 32508039 DOI: 10.1002/ctm2.32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
68 Cheng W, Liu J, Zhi M, Shen D, Shao M, Zhang C, Wang G, Jiang Z. Stress and autonomic nerve dysfunction monitoring in perioperative gastric cancer patients using a smart device. Ann Noninvasive Electrocardiol 2021;:e12903. [PMID: 34669995 DOI: 10.1111/anec.12903] [Reference Citation Analysis]
69 Zeng ZL, Zhu Q, Zhao Z, Zu X, Liu J. Magic and mystery of microRNA-32. J Cell Mol Med 2021;25:8588-601. [PMID: 34405957 DOI: 10.1111/jcmm.16861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Liu Z, Wang Y, Shan F, Ying X, Zhang Y, Li S, Jia Y, Miao R, Xue K, Li Z, Li Z, Ji J. Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol 2021. [PMID: 34327603 DOI: 10.1245/s10434-021-10087-x] [Reference Citation Analysis]
71 Hao D, Zhang Z, Ji Y. Responsive polymeric drug delivery systems for combination anticancer therapy: experimental design and computational insights. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2021.1960340] [Reference Citation Analysis]
72 Zheng H, Xie Q, Zhan M, Jin C, Li Q. Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer. Patient Prefer Adherence 2021;15:77-85. [PMID: 33519193 DOI: 10.2147/PPA.S286860] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Zhang W, Chen H, Zhang G, Jin G. A nomogram for predicting lymph node metastasis in superficial esophageal squamous cell carcinoma. J Biomed Res 2021;35:361-70. [PMID: 34628403 DOI: 10.7555/JBR.35.20210034] [Reference Citation Analysis]
74 Dong X, Chen C, Deng X, Liu Y, Duan Q, Peng Z, Luo Z, Shen L. A novel mechanism for C1GALT1 in the regulation of gastric cancer progression. Cell Biosci 2021;11:166. [PMID: 34452648 DOI: 10.1186/s13578-021-00678-2] [Reference Citation Analysis]
75 Xu W, Ma Q, Wang L, He C, Lu S, Ni Z, Hua Z, Zhu Z, Yang Z, Zheng Y, Feng R, Yan C, Li C, Yao X, Chen M, Liu W, Yan M, Zhu Z. Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy. Front Oncol 2021;11:607640. [PMID: 33937020 DOI: 10.3389/fonc.2021.607640] [Reference Citation Analysis]
76 Ding GW, Gu XY, Dai Z, Pan HW, Wang XY, Zhang H, Fan Y. Association of Genetic Polymorphisms in FOXA1 with the Progression of Genetic Susceptibility to Gastric Cancer. Gastroenterol Res Pract 2020;2020:3075837. [PMID: 32411194 DOI: 10.1155/2020/3075837] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Hui Y, Wang J, Han J, Guo Z, Sun S, Wu Z, Wang Y, Han Z, Chen X. Male mammary gland development after apatinib therapy in advanced gastric cancer: A case report. Medicine (Baltimore) 2020;99:e20727. [PMID: 32664067 DOI: 10.1097/MD.0000000000020727] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Li Z, Liu Z, Yu Z. Application Effect of Somatostatin Combined with Transnasal Ileus Catheterization in Patients with Acute Intestinal Obstruction and Advanced Gastric Cancer. Comput Intell Neurosci 2022;2022:9747880. [PMID: 35726291 DOI: 10.1155/2022/9747880] [Reference Citation Analysis]
79 Pan B, Zhang W, Chen W, Zheng J, Yang X, Sun J, Sun X, Chen X, Shen X. Establishment of the Radiologic Tumor Invasion Index Based on Radiomics Splenic Features and Clinical Factors to Predict Serous Invasion of Gastric Cancer. Front Oncol 2021;11:682456. [PMID: 34434892 DOI: 10.3389/fonc.2021.682456] [Reference Citation Analysis]
80 Yu S, Wang Y, Cheng X, Lv M, Cui Y, Li W, Yu Y, Li Q, Liu T. Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients. Cancer Manag Res 2020;12:10091-101. [PMID: 33116865 DOI: 10.2147/CMAR.S270387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Ren Y, Huo M, Dong Z, Li Z. "Lateral approach" for infra-pyloric lymphadenectomy in laparoscopic radical gastrectomy: A video vignette. Asian J Surg 2022:S1015-9584(22)00121-X. [PMID: 35300899 DOI: 10.1016/j.asjsur.2022.02.023] [Reference Citation Analysis]
82 Li S, Liao R, Sheng X, Luo X, Zhang X, Wen X, Zhou J, Peng K. Hydrogen Gas in Cancer Treatment. Front Oncol 2019;9:696. [PMID: 31448225 DOI: 10.3389/fonc.2019.00696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
83 Yang Q, Song C, Wang P, Ye H, Dai L, Zhang J, Wang K. Polymorphism of TUSC7 associated with gastric cancer susceptibility and binding with miR-133a-3p: a population-based case-control study. Int J Clin Oncol 2021;26:1469-76. [PMID: 33886026 DOI: 10.1007/s10147-021-01924-w] [Reference Citation Analysis]
84 Chang X, Guo X, Li X, Han X, Li X, Liu X, Ren J. Potential Value of Radiomics in the Identification of Stage T3 and T4a Esophagogastric Junction Adenocarcinoma Based on Contrast-Enhanced CT Images. Front Oncol 2021;11:627947. [PMID: 33747947 DOI: 10.3389/fonc.2021.627947] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Mei Y, Feng X, Feng T, Yan M, Zhu Z, Li T, Zhu Z. Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study. Front Pharmacol 2022;13:845261. [DOI: 10.3389/fphar.2022.845261] [Reference Citation Analysis]
86 Diao F, Lai W, Chu Z. S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer. Cancer Commun (Lond) 2019;39:65. [PMID: 31655618 DOI: 10.1186/s40880-019-0408-2] [Reference Citation Analysis]
87 Rim CH, Shin IS, Lee HY, Yoon WS, Park S. Oncologic Benefit of Adjuvant Chemoradiation after D2 Gastrectomy: A Stepwise Hierarchical Pooled Analysis and Systematic Review. Cancers (Basel) 2020;12:E2125. [PMID: 32751879 DOI: 10.3390/cancers12082125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 Zhao L, Li J, Bai C, Nie Y, Lin G. Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China. Front Oncol 2019;9:1155. [PMID: 31737573 DOI: 10.3389/fonc.2019.01155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
89 Xu X, Zheng G, Zhang T, Zhao Y, Zheng Z. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response. Cancer Chemother Pharmacol 2019;84:635-46. [DOI: 10.1007/s00280-019-03893-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
90 Huang Y, Zhang H, Gu X, Qin S, Zheng M, Shi X, Peng C, Ju S. Elucidating the Role of Serum tRF-31-U5YKFN8DYDZDD as a Novel Diagnostic Biomarker in Gastric Cancer (GC). Front Oncol 2021;11:723753. [PMID: 34497770 DOI: 10.3389/fonc.2021.723753] [Reference Citation Analysis]
91 Shao J, Liang R, Ding D, Zheng X, Zhu X, Hu S, Wei H, Wei B. A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer. Int J Nanomedicine 2021;16:2897-915. [PMID: 33907399 DOI: 10.2147/IJN.S289310] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Alsina M, Tabernero J, Diez M. Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond. Cancers 2022;14:1408. [DOI: 10.3390/cancers14061408] [Reference Citation Analysis]
93 Qiu MZ, He CY, Lu SX, Guan WL, Wang F, Wang XJ, Jin Y, Wang FH, Li YH, Shao JY, Zhou ZW, Yun JP, Xu RH. Prospective observation: Clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patients. Int J Cancer 2020;146:272-80. [PMID: 31162842 DOI: 10.1002/ijc.32490] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
94 Liu ZN, Wang YK, Zhang L, Jia YN, Fei S, Ying XJ, Zhang Y, Li SX, Sun Y, Li ZY, Ji JF. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy. World J Gastrointest Oncol 2021; 13(12): 2161-2179 [DOI: 10.4251/wjgo.v13.i12.2161] [Reference Citation Analysis]
95 Peng W, Zhou Z, Zhong Y, Sun Y, Wang Y, Zhu Z, Jiao W, Bai M, Sun J, Lu J, Yin H. Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer. Sci Rep 2019;9:19084. [PMID: 31836775 DOI: 10.1038/s41598-019-55641-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
96 Fu Y, Sun H. Biogenesis, cellular effects, and biomarker value of circHIPK3. Cancer Cell Int 2021;21:256. [PMID: 33975598 DOI: 10.1186/s12935-021-01956-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Lin B, Wang Y, Zhao K, Lü WD, Hui X, Ma Y, Lv R. Exosome-based rare earth nanoparticles for targeted in situ and metastatic tumor imaging with chemo-assisted immunotherapy. Biomater Sci 2021. [PMID: 34940770 DOI: 10.1039/d1bm01809d] [Reference Citation Analysis]
98 Yang Z, Yuan F, Lu S, Xu W, Wu J, Xi W, Shi M, Wang Z, Ni Z, He C, Yao X, Zheng Y, Zhu Z, Liu W, Zhang J, Zhang H, Li C, Yan C, Yan M, Zhu Z. Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study. Front Oncol 2022;12:905922. [DOI: 10.3389/fonc.2022.905922] [Reference Citation Analysis]
99 Cheng X, Yang F, Wang Y, Nie W, Mahendra Upadhyay A, Zhang M, Wang Q, Yan Z. Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis. Can J Gastroenterol Hepatol 2022;2022:6015877. [PMID: 35719323 DOI: 10.1155/2022/6015877] [Reference Citation Analysis]
100 Zhang C, Zhou W, Wang J, Zhang J, Zhang C. Investigation of the quantitative detection of serum Helicobacter pylori antibody in clinical laboratories in China. J Clin Lab Anal 2021;:e24069. [PMID: 34783398 DOI: 10.1002/jcla.24069] [Reference Citation Analysis]
101 Wang Y, Liu W, Yu Y, Liu JJ, Jiang L, Xue HD, Lei J, Jin Z, Yu JC. Prediction of the Depth of Tumor Invasion in Gastric Cancer: Potential Role of CT Radiomics. Acad Radiol 2020;27:1077-84. [PMID: 31761666 DOI: 10.1016/j.acra.2019.10.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
102 Diao F. Targeted Sequencing Analysis of Matched Cell-Free DNA and White Blood Cells: A Facile Method for Detection of Residual Disease in Gastric Cancer. Glob Med Genet 2020;7:27-9. [PMID: 32939511 DOI: 10.1055/s-0040-1716333] [Reference Citation Analysis]
103 Xu JL, Yuan L, Hu C, Weng CY, Xu HD, Shi YF, Huang L, Ying JE, Xu ZY, Qin JJ, Cheng XD. Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment. Front Pharmacol 2022;13:911663. [PMID: 35656301 DOI: 10.3389/fphar.2022.911663] [Reference Citation Analysis]
104 Jin Y, Chen DL, Wang F, Yang CP, Chen XX, You JQ, Huang JS, Shao Y, Zhu DQ, Ouyang YM, Luo HY, Wang ZQ, Wang FH, Li YH, Xu RH, Zhang DS. The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors. Mol Cancer 2020;19:154. [PMID: 33126883 DOI: 10.1186/s12943-020-01274-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
105 Xiao AT, Tong YX, Xu XS, Zhou Y, Zhang S. Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy. Front Oncol 2020;10:692. [PMID: 32426291 DOI: 10.3389/fonc.2020.00692] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Xu W, Liu W, Wang L, He C, Lu S, Ni Z, Hua Z, Zhu Z, Sah BK, Yang Z, Zheng Y, Feng R, Li C, Yao X, Chen M, Yan C, Yan M, Zhu Z. Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy? Front Oncol 2021;11:709617. [PMID: 34540676 DOI: 10.3389/fonc.2021.709617] [Reference Citation Analysis]
107 Hu X, Wang Z, Wang Q, Chen K, Han Q, Bai S, Du J, Chen W. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering. Biomed Pharmacother 2021;144:112222. [PMID: 34607103 DOI: 10.1016/j.biopha.2021.112222] [Reference Citation Analysis]
108 Song Z, Jia N, Li W, Zhang XY. LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p. Onco Targets Ther 2020;13:10877-87. [PMID: 33149605 DOI: 10.2147/OTT.S267915] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
109 Qiu HB. Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma. Thorac Cancer 2020;11:3419-21. [PMID: 33043992 DOI: 10.1111/1759-7714.13690] [Reference Citation Analysis]
110 Deng ZJ, Nie RC, Lu J, Chen XJ, Xiang J, Huang CM, Chen YB, Peng JS, Chen S. Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research. BMC Gastroenterol 2021;21:363. [PMID: 34620108 DOI: 10.1186/s12876-021-01937-9] [Reference Citation Analysis]
111 Wu L, Shang R, Sharma P, Zhou W, Liu J, Yao L, Dong Z, Yuan J, Zeng Z, Yu Y, He C, Xiong Q, Li Y, Deng Y, Cao Z, Huang C, Zhou R, Li H, Hu G, Chen Y, Wang Y, He X, Zhu Y, Yu H. Effect of a deep learning-based system on the miss rate of gastric neoplasms during upper gastrointestinal endoscopy: a single-centre, tandem, randomised controlled trial. Lancet Gastroenterol Hepatol 2021;6:700-8. [PMID: 34297944 DOI: 10.1016/S2468-1253(21)00216-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 He Q, Zhu J, Wang A, Ji K, Ji X, Zhang J, Wu X, Li X, Bu Z, Ji J. A decision analysis comparing three strategies for peritoneal lavage cytology testing in staging of gastric cancer in China. Cancer Med 2020;9:8940-9. [PMID: 33047873 DOI: 10.1002/cam4.3518] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Lee JS, Lee JH, Kim J, Na HK, Ahn JY, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Predictive Role of Endoscopic Surveillance after Total Gastrectomy with R0 Resection for Gastric Cancer. J Korean Med Sci 2021;36:e88. [PMID: 33847079 DOI: 10.3346/jkms.2021.36.e88] [Reference Citation Analysis]
114 Hu W, Li C, Li X, Rahaman MM, Ma J, Zhang Y, Chen H, Liu W, Sun C, Yao Y, Sun H, Grzegorzek M. GasHisSDB: A new gastric histopathology image dataset for computer aided diagnosis of gastric cancer. Comput Biol Med 2022;142:105207. [PMID: 35016101 DOI: 10.1016/j.compbiomed.2021.105207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
115 Peng Z, Liu T, Wei J, Wang A, He Y, Yang L, Zhang X, Fan N, Luo S, Li Z, Gu K, Lu J, Xu J, Fan Q, Xu R, Zhang L, Li E, Sun Y, Yu G, Bai C, Liu Y, Zeng J, Ying J, Liang X, Xu N, Gao C, Shu Y, Ma D, Dai G, Li S, Deng T, Cui Y, Fang J, Ba Y, Shen L. Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study. Cancer Commun (Lond) 2021;41:1173-82. [PMID: 34665942 DOI: 10.1002/cac2.12214] [Reference Citation Analysis]
116 Ren M, Zhou X, Gu M, Jiao W, Yu M, Wang Y, Liu S, Yang J, Ji F. Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress‑mediated apoptosis and G2/M phase arrest. Oncol Rep 2020;44:1605-15. [PMID: 32945472 DOI: 10.3892/or.2020.7708] [Reference Citation Analysis]
117 Huang Q, Read M, Gold JS, Zou XP. Unraveling the identity of gastric cardiac cancer. J Dig Dis 2020;21:674-86. [PMID: 32975049 DOI: 10.1111/1751-2980.12945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Qu Y, Gao N, Wu T. Expression and clinical significance of SYNE1 and MAGI2 gene promoter methylation in gastric cancer. Medicine (Baltimore) 2021;100:e23788. [PMID: 33530176 DOI: 10.1097/MD.0000000000023788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Huang L, Zhang X, Wei Z, Xu A. Importance of Examined Lymph Node Number in Accurate Staging and Enhanced Survival in Resected Gastric Adenocarcinoma-The More, the Better? A Cohort Study of 8,696 Cases From the US and China, 2010-2016. Front Oncol 2020;10:539030. [PMID: 33585181 DOI: 10.3389/fonc.2020.539030] [Reference Citation Analysis]
120 García AM, Sánchez W. Adenocarcinoma indiferenciado como factor predictor de metástasis ganglionares en cáncer gástrico. Rev Colomb Cir 2021;36:620-5. [DOI: 10.30944/20117582.860] [Reference Citation Analysis]
121 Wang F, Wei XL, Wang FH, Xu N, Shen L, Dai GH, Yuan XL, Chen Y, Yang SJ, Shi JH, Hu XC, Lin XY, Zhang QY, Feng JF, Ba Y, Liu YP, Li W, Shu YQ, Jiang Y, Li Q, Wang JW, Wu H, Feng H, Yao S, Xu RH. Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432. Ann Oncol. 2019;30:1479-1486. [PMID: 31236579 DOI: 10.1093/annonc/mdz197] [Cited by in Crossref: 87] [Cited by in F6Publishing: 95] [Article Influence: 43.5] [Reference Citation Analysis]
122 Chen XL, Hong LL, Wang KL, Liu X, Wang JL, Lei L, Xu ZY, Cheng XD, Ling ZQ. Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-κB pathway. Int J Biol Sci 2019;15:2075-86. [PMID: 31592231 DOI: 10.7150/ijbs.23802] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
123 Yu Z, Rong Z, Sheng J, Luo Z, Zhang J, Li T, Zhu Z, Fu Z, Qiu Z, Huang C. Aberrant Non-Coding RNA Expressed in Gastric Cancer and Its Diagnostic Value. Front Oncol 2021;11:606764. [PMID: 34295803 DOI: 10.3389/fonc.2021.606764] [Reference Citation Analysis]
124 Xu W, Wang L, Yan C, He C, Lu S, Ni Z, Hua Z, Zhu Z, Sah BK, Yang Z, Zheng Y, Feng R, Li C, Yao X, Chen M, Liu W, Yan M, Zhu Z. Neoadjuvant Chemotherapy Versus Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis. Front Oncol 2021;11:718556. [PMID: 34497768 DOI: 10.3389/fonc.2021.718556] [Reference Citation Analysis]
125 Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. Lancet Oncol 2021;22:1081-92. [PMID: 34252374 DOI: 10.1016/S1470-2045(21)00297-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Anderson E, LeVee A, Kim S, Atkins K, Guan M, Placencio-Hickok V, Moshayedi N, Hendifar A, Osipov A, Gangi A, Burch M, Waters K, Cho M, Klempner S, Chao J, Kamrava M, Gong J. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA Netw Open 2021;4:e2138432. [PMID: 34889947 DOI: 10.1001/jamanetworkopen.2021.38432] [Reference Citation Analysis]
127 Zhang Y, Zhang B, Yang J, Zhang J, Zhang W. Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer. Cancer Manag Res 2021;13:2279-86. [PMID: 33732020 DOI: 10.2147/CMAR.S304093] [Reference Citation Analysis]
128 Wu ZW, Sha Y, Chen Q, Hou J, Sun Y, Lu WK, Chen J, Yu LJ. Novel intergenic KIF5B-MET fusion variant in a patient with gastric cancer: A case report. World J Clin Cases 2021; 9(14): 3350-3355 [PMID: 34002144 DOI: 10.12998/wjcc.v9.i14.3350] [Reference Citation Analysis]
129 Zhang Y, Zhang JQ, Zhang T, Xue H, Zuo WB, Li YN, Zhao Y, Sun G, Fu ZR, Zhang Q, Zhao X, Teng Y, Wang AQ, Li JZ, Wang Y, Jin CH. Calycosin Induces Gastric Cancer Cell Apoptosis via the ROS-Mediated MAPK/STAT3/NF-κB Pathway. Onco Targets Ther 2021;14:2505-17. [PMID: 33883905 DOI: 10.2147/OTT.S292388] [Reference Citation Analysis]
130 Pan WT, Zhou SN, Pan MX, Luo QY, Zhang L, Yang DJ, Qiu M. Role of Systemic Treatment for Advanced/Metastatic Gastric Carcinoma in the Third-Line Setting: A Bayesian Network Analysis. Front Oncol 2020;10:513. [PMID: 32391262 DOI: 10.3389/fonc.2020.00513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Shin CI, Kim SH. Normal and Abnormal Postoperative Imaging Findings after Gastric Oncologic and Bariatric Surgery. Korean J Radiol 2020;21:793-811. [PMID: 32524781 DOI: 10.3348/kjr.2019.0822] [Reference Citation Analysis]
132 Wang T, Zhang J, Cui L. Apatinib inhibits gastric carcinoma development by regulating the expression levels of IL-17 via the Bax/Bcl-2 signaling pathway. Exp Ther Med 2021;21:654. [PMID: 33968184 DOI: 10.3892/etm.2021.10086] [Reference Citation Analysis]
133 Cai Q, Zhou W, Li J, Ou X, Chen C, Cai S, He W, Xu J, He Y. Association of Preoperative Serum Carcinoembryonic Antigen and Gastric Cancer Recurrence: A Large Cohort Study. J Cancer 2021;12:397-403. [PMID: 33391436 DOI: 10.7150/jca.47899] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Hou C, Yang D, Zhang Y, Li Y, He Z, Dai X, Lu Q, Wang S, Zhang X, Liu Y. Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study. Integr Cancer Ther 2021;20:15347354211058464. [PMID: 34781754 DOI: 10.1177/15347354211058464] [Reference Citation Analysis]
135 Zhang K, Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Ther Adv Med Oncol. 2020;12:1758835920904803. [PMID: 32127925 DOI: 10.1177/1758835920904803] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
136 Ma L, Wang Y. JAK2/STAT3 inhibitor reduced 5-FU resistance and autophagy through ATF6-mediated ER stress. J Recept Signal Transduct Res 2021;:1-8. [PMID: 33599179 DOI: 10.1080/10799893.2021.1887219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Ge J, Liu T, Lei T, Li X, Song K, Azizi S, Liu H, Tang M. Retrospective Cohort Study of Intraoperative Administration of Sustained-Release 5-Fluorouracil Implants in Advanced Gastric Cancer Patients. Front Pharmacol 2021;12:659258. [PMID: 33927633 DOI: 10.3389/fphar.2021.659258] [Reference Citation Analysis]
138 Wei XL, Xu JY, Wang DS, Chen DL, Ren C, Li JN, Wang F, Wang FH, Xu RH. Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer. Ther Adv Med Oncol 2021;13:1758835921988996. [PMID: 33613701 DOI: 10.1177/1758835921988996] [Reference Citation Analysis]
139 Niu PH, Zhao LL, Wu HL, Zhao DB, Chen YT. Artificial intelligence in gastric cancer: Application and future perspectives. World J Gastroenterol 2020; 26(36): 5408-5419 [PMID: 33024393 DOI: 10.3748/wjg.v26.i36.5408] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
140 Wang X, Li S, Sun Y, Li K, Shen X, Xue Y, Liang P, Li G, Chen L, Zhao Q, Li G, Fu W, Liang H, Xin H, Suo J, Fang X, Zheng Z, Xu Z, Chen H, Zhou Y, He Y, Huang H, Zhu L, Yang K, Ji J, Ye Y, Zhang Z, Li F, Wang X, Tian Y, Park S, Chen L. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial. BMC Cancer 2021;21:20. [PMID: 33402102 DOI: 10.1186/s12885-020-07764-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Lian B, Chen J, Li Z, Ji G, Wang S, Zhao Q, Li M. Risk Factors and Clavien-Dindo Classification of Postoperative Complications After Laparoscopic and Open Gastrectomies for Gastric Cancer: A Single-Center, Large Sample, Retrospective Cohort Study. Cancer Manag Res 2020;12:12029-39. [PMID: 33262653 DOI: 10.2147/CMAR.S275621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Qiu H. Safety and efficacy of toripalimab in advanced gastric cancer: A new clinical trial bringing hope for immunotherapy in gastric cancer. Cancer Commun (Lond) 2020;40:194-6. [PMID: 32277740 DOI: 10.1002/cac2.12019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
143 Wang X, Sun J, Zhang W, Yang X, Zhu C, Pan B, Zeng Y, Xu J, Chen X, Shen X. Use of radiomics to extract splenic features to predict prognosis of patients with gastric cancer. Eur J Surg Oncol 2020;46:1932-40. [PMID: 32694053 DOI: 10.1016/j.ejso.2020.06.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
144 Su JW, Zeng YT, Luo SA, Sun YY, Huang CY. Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients. J Oncol 2022;2022:2286040. [PMID: 35646121 DOI: 10.1155/2022/2286040] [Reference Citation Analysis]
145 Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A, Liu T, Schenker M, Yanez P, Tehfe M, Kowalyszyn R, Karamouzis MV, Bruges R, Zander T, Pazo-Cid R, Hitre E, Feeney K, Cleary JM, Poulart V, Cullen D, Lei M, Xiao H, Kondo K, Li M, Ajani JA. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 2021;398:27-40. [PMID: 34102137 DOI: 10.1016/S0140-6736(21)00797-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
146 Chen Y, Xu S, Huang C, Ling Y, Liang C, Miao Y, Sun X, Li Y, Zhou Z. Cancer cells invasion to the gastric bare area adipose tissue: a poor prognostic predictor for gastric cancer. World J Surg Oncol 2020;18:300. [PMID: 33187517 DOI: 10.1186/s12957-020-02066-5] [Reference Citation Analysis]
147 Wang Y, Wang Y, Wu W, Lu X, An T, Jiang J. Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer. World J Surg Oncol 2021;19:102. [PMID: 33827589 DOI: 10.1186/s12957-021-02218-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Cheng LJ, Zhou WJ, An TL, Wei ZW, Yuan C, Xiao X, Hao TF, Yin SC, Zhang CH, He YL. Prognostic impact of anatomical extent of metastatic lymph node on gastric cancer: a propensity score matching study. Clin Transl Oncol 2021;23:773-82. [PMID: 32772226 DOI: 10.1007/s12094-020-02468-7] [Reference Citation Analysis]
149 Fang L, Lv J, Xuan Z, Li B, Li Z, He Z, Li F, Xu J, Wang S, Xia Y, Jiang T, Zhang L, Wang L, Zhang D, Xu H, Yang L, Xu Z, Wang W. Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2‐mediated autophagy. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.708] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Chen W, Wang S, Dong D, Gao X, Zhou K, Li J, Lv B, Li H, Wu X, Fang M, Tian J, Xu M. Evaluation of Lymph Node Metastasis in Advanced Gastric Cancer Using Magnetic Resonance Imaging-Based Radiomics. Front Oncol. 2019;9:1265. [PMID: 31824847 DOI: 10.3389/fonc.2019.01265] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
151 Jin P, Ji X, Ma S, Kang W, Liu H, Li Y, Ma F, Hu H, Xiong J, Tian Y. Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node. Clin Res Hepatol Gastroenterol 2021;45:101634. [PMID: 33662780 DOI: 10.1016/j.clinre.2021.101634] [Reference Citation Analysis]
152 Jing C, Bai Z, Zhang J, Jiang H, Yang X, Yan S, Yin J, Cai J, Zhang Z, Deng W. Apatinib plus S-1 for previously treated, advanced gastric or gastro-oesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study. J Gastrointest Oncol 2021;12:2035-44. [PMID: 34790371 DOI: 10.21037/jgo-21-186] [Reference Citation Analysis]
153 Qiu MZ, He CY, Yang DJ, Zhou DL, Zhao BW, Wang XJ, Yang LQ, Lu SX, Wang FH, Xu RH. Observational cohort study of clinical outcome in Epstein-Barr virus associated gastric cancer patients. Ther Adv Med Oncol 2020;12:1758835920937434. [PMID: 32670421 DOI: 10.1177/1758835920937434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Zhu L, Wang H, Jiang C, Li W, Zhai S, Cai X, Wang X, Liao L, Tao F, Jin D, Chen G, Xia Y, Mao JH, Li B, Wang P, Hang B. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study. EBioMedicine 2020;61:103023. [PMID: 33069062 DOI: 10.1016/j.ebiom.2020.103023] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
155 Liu W, Hu W, Hou K, Zhu S. Circular RNA Paired-Related Homeobox 1 Promotes Gastric Carcinoma Cell Progression via Regulating MicroRNA-665/YWHAZ Axis. Dig Dis Sci. [DOI: 10.1007/s10620-020-06705-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
156 Zheng Y, Wang Z, Yan C, Yan M, Hou Z, Zheng R, Zhu Z, Li C. Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma. Ann Transl Med 2020;8:1684. [PMID: 33490196 DOI: 10.21037/atm-20-7802] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Qiu H. Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France. Cancer Commun (Lond) 2019;39:45. [PMID: 31395093 DOI: 10.1186/s40880-019-0391-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
158 Xue B, Jiang J, Chen L, Wu S, Zheng X, Zheng X, Tang K. Development and Validation of a Radiomics Model Based on 18F-FDG PET of Primary Gastric Cancer for Predicting Peritoneal Metastasis. Front Oncol 2021;11:740111. [PMID: 34765549 DOI: 10.3389/fonc.2021.740111] [Reference Citation Analysis]
159 Zeng X, Yang SW, Yang HQ, Chen Y, Pan QJ. Effect of bifid triple viable combined with enteral nutrition support on gastrointestinal function and nutritional indexes in patients with gastric cancer after operation. Shijie Huaren Xiaohua Zazhi 2020; 28(11): 410-416 [DOI: 10.11569/wcjd.v28.i11.410] [Reference Citation Analysis]
160 Alsina M, Diez M, Tabernero J. Emerging biological drugs for the treatment of gastroesophageal adenocarcinoma. Expert Opin Emerg Drugs 2021;26:385-400. [PMID: 34814781 DOI: 10.1080/14728214.2021.2010705] [Reference Citation Analysis]
161 Su H, Li X, Huang L, Cao J, Zhang M, Vedarethinam V, Di W, Hu Z, Qian K. Plasmonic Alloys Reveal a Distinct Metabolic Phenotype of Early Gastric Cancer. Adv Mater 2021;33:e2007978. [PMID: 33742513 DOI: 10.1002/adma.202007978] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 28.0] [Reference Citation Analysis]
162 Zhang X, Ai D, Wang J, Chen Y, Liu Q, Deng J, Yang H, Nie Y, Chen W, Zhao W, Zhao K. The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial. Front Oncol 2021;11:669575. [PMID: 34295813 DOI: 10.3389/fonc.2021.669575] [Reference Citation Analysis]
163 Yan Y, Wang D, Liu Y, Lu L, Wang X, Zhao Z, Li C, Liu J, Li W, Fu W. Optimal Reconstruction After Laparoscopic Distal Gastrectomy: A Single-Center Retrospective Study. Cancer Control 2022;29:10732748221087059. [PMID: 35412845 DOI: 10.1177/10732748221087059] [Reference Citation Analysis]
164 Xu B, Chen F, Zhang X, Wang Z, Che K, Wu N, Yu L, Fan X, Liu B, Wei J. Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer. Cancers 2022;14:2758. [DOI: 10.3390/cancers14112758] [Reference Citation Analysis]
165 Feng C, Cheng J, Zeng X, Zhang Y, Hong N, Ye Y, Wang Y. Development and evaluation of a ceMDCT-based preoperative risk stratification model to predict disease-free survival after radical surgery in patients with gastric cancer. Abdom Radiol (NY) 2021;46:4079-89. [PMID: 33811513 DOI: 10.1007/s00261-021-03049-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
166 Ma N, Qiao H, Tao H, Gan X, Shan Z, Chen X, Zhou X. Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101962] [Reference Citation Analysis]
167 You X, Wu J, Wang Y, Liu Q, Cheng Z, Zhao X, Liu G, Huang C, Dai J, Zhou Y, Chen D, Chong Y. Galectin-1 promotes vasculogenic mimicry in gastric adenocarcinoma via the Hedgehog/GLI signaling pathway. Aging (Albany NY) 2020;12:21837-53. [PMID: 33170154 DOI: 10.18632/aging.104000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
168 Yan Y, Li H, Wu S, Wang G, Luo H, Niu J, Cao L, Hu X, Xu H, Jia W, Sun Y, Yao Y, Chen W, Ke L, Hu B, Ji C, Sun Y, Chen J, Li M, He Y. Efficacy and safety of intermittent versus continuous dose apatinib plus docetaxel as second-line therapy in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma: a randomized controlled study. Ann Transl Med 2022;10:205. [PMID: 35280426 DOI: 10.21037/atm-22-546] [Reference Citation Analysis]
169 Zhong Q, Chen QY, Huang XB, Lin GT, Liu ZY, Chen JY, Wang HG, Weng K, Li P, Xie JW, Lin JX, Lu J, Lin M, Huang ZN, Zheng CH, Huang CM. Clinical implications of Indocyanine Green Fluorescence Imaging-Guided laparoscopic lymphadenectomy for patients with gastric cancer: A cohort study from two randomized, controlled trials using individual patient data. Int J Surg 2021;94:106120. [PMID: 34543741 DOI: 10.1016/j.ijsu.2021.106120] [Reference Citation Analysis]
170 Xu J, Ou X, Li J, Cai Q, Sun K, Ye J, Peng J. Overexpression of TC2N is associated with poor prognosis in gastric cancer. J Cancer 2021;12:807-17. [PMID: 33403038 DOI: 10.7150/jca.50653] [Reference Citation Analysis]
171 Chen XJ, Chen GM, Wei YC, Yu H, Wang XC, Zhao ZK, Luo TQ, Nie RC, Zhou ZW. Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis. BMC Cancer 2021;21:188. [PMID: 33622258 DOI: 10.1186/s12885-021-07904-7] [Reference Citation Analysis]
172 Wang X, Ye H, Yan Y, Wu J, Wang N, Chen M. The Preoperative Enhanced Degree of Contrast-enhanced CT Images: A Potential Independent Predictor in Gastric Adenocarcinoma Patients After Radical Gastrectomy. Cancer Manag Res 2020;12:11989-99. [PMID: 33262649 DOI: 10.2147/CMAR.S271879] [Reference Citation Analysis]
173 Li C, Li J, Li Y, Li L, Luo Y, Li J, Zhang Y, Wang Y, Liu X, Zhou X, Gong H, Jin X, Liu Y. Isorhamnetin Promotes MKN-45 Gastric Cancer Cell Apoptosis by Inhibiting PI3K-Mediated Adaptive Autophagy in a Hypoxic Environment. J Agric Food Chem 2021;69:8130-43. [PMID: 34269571 DOI: 10.1021/acs.jafc.1c02620] [Reference Citation Analysis]
174 Yan L, Qu J, Li J, Zhang H, Lu Y, Gao J. Predicting T and N Staging of Resectable Gastric Cancer According to Whole Tumor Histogram Analysis About a Non-Cartesian k-Space Acquisition DCE-MRI: A Feasibility Study. Cancer Manag Res 2021;13:7951-60. [PMID: 34703316 DOI: 10.2147/CMAR.S326874] [Reference Citation Analysis]
175 Chen X, Sun X, Li X, Xu L, Yu W. LncRNA-HEIH is a Novel Diagnostic and Predictive Biomarker in Gastric Cancer. Genet Test Mol Biomarkers 2021;25:284-92. [PMID: 33877891 DOI: 10.1089/gtmb.2020.0270] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Qian Y, Cai S. A safe and effective surgical navigation technique in laparoscopic radical gastrectomy: Indocyanine green-mediated near-infrared fluorescent imaging. Cancer Commun (Lond) 2020;40:270-2. [PMID: 32525596 DOI: 10.1002/cac2.12033] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Zhang Y, Zhang P, Rong Z, Huang C. One stomach, two subtypes of carcinoma—the differences between distal and proximal gastric cancer. Gastroenterology Report 2021;9:489-504. [DOI: 10.1093/gastro/goab050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Bie LY, Li N, Deng WY, Lu XY, Guo P, Luo SX. Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen. Onco Targets Ther 2020;13:1705-15. [PMID: 32158234 DOI: 10.2147/OTT.S233086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]